CA2207500A1 - Piperazine 2,5 dione derivatives as modulators of multi-drug resistance - Google Patents
Piperazine 2,5 dione derivatives as modulators of multi-drug resistanceInfo
- Publication number
- CA2207500A1 CA2207500A1 CA002207500A CA2207500A CA2207500A1 CA 2207500 A1 CA2207500 A1 CA 2207500A1 CA 002207500 A CA002207500 A CA 002207500A CA 2207500 A CA2207500 A CA 2207500A CA 2207500 A1 CA2207500 A1 CA 2207500A1
- Authority
- CA
- Canada
- Prior art keywords
- phenyl
- ethyl
- tetrahydro
- methylbenzamide
- piperazinylidene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9426224.3A GB9426224D0 (en) | 1994-12-23 | 1994-12-23 | Pharmaceutical compounds |
| GB9426224.3 | 1994-12-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2207500A1 true CA2207500A1 (en) | 1996-07-04 |
Family
ID=10766589
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002207500A Abandoned CA2207500A1 (en) | 1994-12-23 | 1995-12-22 | Piperazine 2,5 dione derivatives as modulators of multi-drug resistance |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0799222A1 (cs) |
| JP (1) | JPH10511384A (cs) |
| CN (1) | CN1175253A (cs) |
| AU (1) | AU698828B2 (cs) |
| BG (1) | BG101602A (cs) |
| BR (1) | BR9510410A (cs) |
| CA (1) | CA2207500A1 (cs) |
| CZ (1) | CZ190097A3 (cs) |
| FI (1) | FI972660A7 (cs) |
| GB (1) | GB9426224D0 (cs) |
| HU (1) | HUT77943A (cs) |
| IL (1) | IL116525A0 (cs) |
| NO (1) | NO972937L (cs) |
| NZ (1) | NZ297847A (cs) |
| PL (1) | PL320916A1 (cs) |
| SK (1) | SK83697A3 (cs) |
| TW (1) | TW358094B (cs) |
| WO (1) | WO1996020190A1 (cs) |
| ZA (1) | ZA9510909B (cs) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9717576D0 (en) * | 1997-08-19 | 1997-10-22 | Xenova Ltd | Pharmaceutical compounds |
| CN100354265C (zh) * | 1996-10-18 | 2007-12-12 | 埃克森诺瓦有限公司 | 邻氨基苯甲酸衍生物及其制备方法和作为多种抗性调节剂的用途 |
| GB9708805D0 (en) | 1997-05-01 | 1997-06-25 | Smithkline Beecham Plc | Compounds |
| GB9810876D0 (en) | 1998-05-20 | 1998-07-22 | Smithkline Beecham Plc | Compounds |
| SK4782001A3 (en) | 1998-10-08 | 2001-11-06 | Smithkline Beecham Plc | Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| MXPA02006826A (es) * | 2000-01-18 | 2004-04-05 | Nereus Phamraceuticals Inc | Un inhibidor de division celular y un metodo de produccion del mismo. |
| US7220414B2 (en) | 2000-09-06 | 2007-05-22 | A.P. Pharma, Inc. | Degradable polyacetal polymers |
| US6693099B2 (en) | 2000-10-17 | 2004-02-17 | The Procter & Gamble Company | Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance |
| US7935704B2 (en) | 2003-08-01 | 2011-05-03 | Nereus Pharmaceuticals, Inc. | Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| US7919497B2 (en) | 2002-08-02 | 2011-04-05 | Nereus Pharmaceuticals, Inc. | Analogs of dehydrophenylahistins and their therapeutic use |
| ATE374767T1 (de) | 2002-08-02 | 2007-10-15 | Nereus Pharmaceuticals Inc | Dehydrophenylahistine und analoge davon sowie ein verfahren zur herstellung von dehydrophenylahistinen und analogen davon |
| US8129527B2 (en) | 2006-11-03 | 2012-03-06 | Nereus Pharmacuticals, Inc. | Analogs of dehydrophenylahistins and their therapeutic use |
| CN103396372B (zh) * | 2013-08-09 | 2015-05-20 | 中国科学院南海海洋研究所 | 一类2,5-二酮哌嗪衍生物及其制备方法和在制备抗海洋污损生物防除剂中的应用 |
| CA2978679A1 (en) | 2015-03-06 | 2016-09-15 | Beyondspring Pharmaceuticals, Inc. | Method of treating a brain tumor |
| CA2978567A1 (en) | 2015-03-06 | 2016-09-15 | Beyondspring Pharmaceuticals, Inc. | Method of treating cancer associated with a ras mutation using plinabulin |
| KR102680823B1 (ko) | 2015-07-13 | 2024-07-03 | 비욘드스프링 파마수티컬스, 인코포레이티드. | 플리나불린 조성물 |
| BR112018016054A2 (pt) | 2016-02-08 | 2019-02-12 | Beyondspring Pharmaceuticals, Inc. | composições farmacêuticas e/ou métodos para tratar câncer e/ou para romper vasculatura de tumor associada ao câncer em indivíduo |
| EP3463337A4 (en) | 2016-06-06 | 2020-02-12 | Beyondspring Pharmaceuticals, Inc. | COMPOSITION AND METHOD FOR REDUCING NEUTROPENIA |
| EP3565812B1 (en) | 2017-01-06 | 2023-12-27 | Beyondspring Pharmaceuticals, Inc. | Tubulin binding compounds and therapeutic use thereof |
| EP3576733A4 (en) | 2017-02-01 | 2020-11-25 | Beyondspring Pharmaceuticals, Inc. | NEUTROPENIA REDUCTION METHOD |
| WO2019147615A1 (en) | 2018-01-24 | 2019-08-01 | Beyondspring Pharmaceuticals, Inc. | Composition and method for reducing thrombocytopenia via the administration of plinabulin |
| WO2022216908A1 (en) | 2021-04-09 | 2022-10-13 | Beyondspring Pharmaceuticals, Inc. | Therapeutic compositions and methods for treating tumors |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2103479T3 (es) * | 1992-07-10 | 1997-09-16 | Glaxo Lab Sa | Derivados de anilida. |
| GB9217331D0 (en) * | 1992-08-14 | 1992-09-30 | Xenova Ltd | Pharmaceutical compounds |
-
1994
- 1994-12-23 GB GBGB9426224.3A patent/GB9426224D0/en active Pending
-
1995
- 1995-12-21 ZA ZA9510909A patent/ZA9510909B/xx unknown
- 1995-12-22 BR BR9510410-0A patent/BR9510410A/pt not_active Application Discontinuation
- 1995-12-22 JP JP8520301A patent/JPH10511384A/ja active Pending
- 1995-12-22 SK SK836-97A patent/SK83697A3/sk unknown
- 1995-12-22 FI FI972660A patent/FI972660A7/fi unknown
- 1995-12-22 PL PL95320916A patent/PL320916A1/xx unknown
- 1995-12-22 WO PCT/GB1995/003027 patent/WO1996020190A1/en not_active Ceased
- 1995-12-22 NZ NZ297847A patent/NZ297847A/en unknown
- 1995-12-22 EP EP95941797A patent/EP0799222A1/en not_active Withdrawn
- 1995-12-22 CA CA002207500A patent/CA2207500A1/en not_active Abandoned
- 1995-12-22 IL IL11652595A patent/IL116525A0/xx unknown
- 1995-12-22 CZ CZ971900A patent/CZ190097A3/cs unknown
- 1995-12-22 CN CN95197672A patent/CN1175253A/zh active Pending
- 1995-12-22 AU AU43100/96A patent/AU698828B2/en not_active Ceased
- 1995-12-22 HU HU9800398A patent/HUT77943A/hu unknown
- 1995-12-23 TW TW084113836A patent/TW358094B/zh active
-
1997
- 1997-06-11 BG BG101602A patent/BG101602A/xx unknown
- 1997-06-23 NO NO972937A patent/NO972937L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL320916A1 (en) | 1997-11-10 |
| SK83697A3 (en) | 1998-05-06 |
| AU698828B2 (en) | 1998-11-05 |
| FI972660L (fi) | 1997-08-22 |
| FI972660A7 (fi) | 1997-08-22 |
| CN1175253A (zh) | 1998-03-04 |
| FI972660A0 (fi) | 1997-06-19 |
| BG101602A (en) | 1998-02-27 |
| NZ297847A (en) | 1999-04-29 |
| CZ190097A3 (cs) | 1998-01-14 |
| WO1996020190A1 (en) | 1996-07-04 |
| AU4310096A (en) | 1996-07-19 |
| HUT77943A (hu) | 1998-12-28 |
| GB9426224D0 (en) | 1995-02-22 |
| NO972937D0 (no) | 1997-06-23 |
| BR9510410A (pt) | 1999-09-08 |
| ZA9510909B (en) | 1996-08-30 |
| IL116525A0 (en) | 1996-03-31 |
| TW358094B (en) | 1999-05-11 |
| JPH10511384A (ja) | 1998-11-04 |
| NO972937L (no) | 1997-06-23 |
| EP0799222A1 (en) | 1997-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2207500A1 (en) | Piperazine 2,5 dione derivatives as modulators of multi-drug resistance | |
| EP1040103B1 (en) | Anilide derivative, production and use thereof | |
| US8680139B2 (en) | Anti-neoplastic compounds, compositions and methods | |
| DE60202452T2 (de) | Pyridazinonaldose reductase inhibitoren | |
| KR102885432B1 (ko) | CCR8 억제제로 Tregs를 표적화하는 방법 및 조성물 | |
| AU2016372048B2 (en) | Heteroarylhydroxypyrimidinones as agonists of the APJ receptor | |
| EP3526198B1 (en) | 3-sulfonyl-5-aminopyridine-2,4-diol apj agonists | |
| JP4548868B2 (ja) | Ｍｄｒモジュレーターとしてのイミダゾール誘導体 | |
| JP2010514689A (ja) | 癌、炎症およびウイルス感染症の処置のためのｃｄｋ阻害剤としてのヘテロアリール−ヘテロアリール化合物 | |
| JP3076066B2 (ja) | クロメン−３−カルボン酸誘導体 | |
| US7361679B2 (en) | 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same | |
| EP0799210B1 (en) | Piperazine-2,5-dione derivatives as modulators of multidrug resistance | |
| WO2023165334A1 (zh) | 酮酰胺类衍生物及其制药用途 | |
| JP5186566B2 (ja) | ジチオロピロロン化合物類、それらの調製及び使用 | |
| CN100430392C (zh) | 氨甲酰型苯并呋喃衍生物 | |
| JPH10298180A (ja) | ドーパミン受容体拮抗作用を有する化合物 | |
| WO1996020179A1 (en) | Piperazine-2,5-dione derivatives as modulators of multi-drug resistance | |
| US5861400A (en) | Pharmaceutical compounds | |
| US6017918A (en) | Phenyl glycine compounds and methods of treating atherosclerosis and restenosis | |
| CN115260194B (zh) | 新型egfr降解剂 | |
| KR101082227B1 (ko) | 피라졸로피리미딘 화합물의 메탄술폰산염, 그 결정 및 그제조 방법 | |
| CA2567483A1 (en) | Pyrazinylmethyl lactam derivatives | |
| JP2002539114A (ja) | 抗腫瘍活性を有する複素環化合物 | |
| CN113493456B (zh) | 一类含中环四氢咔啉-四氢异喹啉化合物的制备和用途 | |
| CN113444092B (zh) | 一类含中环的Renieramycin G衍生物的制备和医药用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |